|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2005-11-23
|
|
pubmed:abstractText |
To examine uveal melanoma cell lines for the expression of human melanoma proteoglycan (NG2) using monoclonal antibody (mAb) 9.2.27 and subsequently to assess the in vitro specificity and cytotoxicity of mAb 9.2.27 conjugated to the alpha-particle-emitting radioisotope 213bismuth (213Bi-9.2.27) for uveal melanoma cells.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0146-0404
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
46
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
4365-71
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16303921-Antibodies, Bispecific,
pubmed-meshheading:16303921-Antigens,
pubmed-meshheading:16303921-Bismuth,
pubmed-meshheading:16303921-Cell Death,
pubmed-meshheading:16303921-Cytotoxicity, Immunologic,
pubmed-meshheading:16303921-Dose-Response Relationship, Drug,
pubmed-meshheading:16303921-Flow Cytometry,
pubmed-meshheading:16303921-Humans,
pubmed-meshheading:16303921-Immunoconjugates,
pubmed-meshheading:16303921-Immunohistochemistry,
pubmed-meshheading:16303921-In Situ Nick-End Labeling,
pubmed-meshheading:16303921-Melanoma,
pubmed-meshheading:16303921-Proteoglycans,
pubmed-meshheading:16303921-Radioimmunotherapy,
pubmed-meshheading:16303921-Radioisotopes,
pubmed-meshheading:16303921-Tumor Cells, Cultured,
pubmed-meshheading:16303921-Uveal Neoplasms
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
In vitro targeting of NG2 antigen by 213Bi-9.2.27 alpha-immunoconjugate induces cytotoxicity in human uveal melanoma cells.
|
|
pubmed:affiliation |
Centre for Experimental Radiation Oncology, Cancer Care Centre, St. George Hospital, Kogarah, NSW, Australia.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, Non-P.H.S.,
Research Support, Non-U.S. Gov't
|
